ERBB2 and breast carcinoma: As popular cellular models for differential HER2 expression, we used SK-BR-3 and MDA-MB-231 breast cancer cell lines and confirmed the respective positive or negative receptor expression by immunofluorescence and immunoblotting (Fig. 4A and Fig. S3A).